(Q42993308)

12 November 2017

title

Hepatitis C virus reactivation in anti-hepatitic C virus-positive renal transplant recipients (English)

1 reference

12 November 2017

1 reference

5

1 reference

12 November 2017

Melon S

1

1 reference

12 November 2017

Galarraga MC

2

1 reference

12 November 2017

Villar M

3

1 reference

12 November 2017

Laures A

4

1 reference

12 November 2017

de Oña M

6

1 reference

12 November 2017

Gomez E

7

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

Transplantation Proceedings

12 November 2017

published in

1 reference

12 November 2017

volume

37

1 reference

12 November 2017

issue

5

1 reference

12 November 2017

page(s)

2083-2085

1 reference

Donor hepatitis C virus status does not adversely affect short-term outcomes in HCV+ recipients in renal transplantation

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.03.045

Hepatitis C in renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.03.045

Impact of hepatitis B and C virus on kidney transplantation outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.03.045

Hepatitis C virus recurrence after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.03.045

Hepatitis C virus infection and renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.03.045

Clinical outcome of HCV infection after renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.03.045

Hepatitis C virus genotype does not affect patient survival among renal transplant candidates. The New England Organ Bank Hepatitis C Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.03.045

Hepatitis C virus infection in dialysis and renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.03.045

Hepatitis C virus infection after renal transplantation: viral load and outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.03.045

High rate of hepatitis C virus clearance in hemodialysis patients after interferon-alpha therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.03.045

Combination of interferon alpha and ribavirin in the treatment of hepatitis C: implications for the clinical nephrologist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.03.045

The impact of hepatitis C virus infection on renal allograft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.03.045

10.1016/J.TRANSPROCEED.2005.03.045

7 January 2021

Identifiers

DOI

1 reference

12 November 2017

1 reference